The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia
Pneumonia is the number one cause of disease and deaths in children under five years old, outside the neonatal period, with the greatest number of cases reported from resource-limited settings. The etiology is variable, with not much information on the local etiology drug resistance profile in many...
Main Authors: | Phuong T. K. Nguyen, Paul D. Robinson, Dominic A. Fitzgerald, Ben J. Marais |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2023.1095166/full |
Similar Items
-
Clinical and laboratory findings in the diagnosis of bacterial pneumonia in children.
by: M Don, et al.
Published: (2008-03-01) -
Antibiotic Prescribing for Lower Respiratory Tract Infections and Community-Acquired Pneumonia: An Italian Pediatric Emergency Department’s Real-Life Experience
by: Luca Pierantoni, et al.
Published: (2023-09-01) -
Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial
by: Claudine A. Blum, et al.
Published: (2023-12-01) -
Vitamin D status of children with lower respiratory tract infections and its correlation with severity of pneumonia: A comparative study
by: Mohammed Mujtaba Qureshi, et al.
Published: (2022-12-01) -
Clinical and immunological characteristics of bacterial pneumonia associated with HIV infection coupled to drug addiction
by: L. V. Puzyreva, et al.
Published: (2020-11-01)